These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Naidu YM; Rosen EM; Zitnick R; Goldberg I; Park M; Naujokas M; Polverini PJ; Nickoloff BJ Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5281-5. PubMed ID: 7515495 [TBL] [Abstract][Full Text] [Related]
8. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. Samaniego F; Markham PD; Gallo RC; Ensoli B J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237 [TBL] [Abstract][Full Text] [Related]
10. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals. Murakami-Mori K; Mori S; Nakamura S J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033 [TBL] [Abstract][Full Text] [Related]
11. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144 [TBL] [Abstract][Full Text] [Related]
12. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis. Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748 [TBL] [Abstract][Full Text] [Related]
13. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients. Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450 [TBL] [Abstract][Full Text] [Related]
14. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Barillari G; Gendelman R; Gallo RC; Ensoli B Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7941-5. PubMed ID: 7690138 [TBL] [Abstract][Full Text] [Related]
15. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells. Murakami-Mori K; Mori S; Bonavida B; Nakamura S J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829 [TBL] [Abstract][Full Text] [Related]
17. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. Thompson EW; Nakamura S; Shima TB; Melchiori A; Martin GR; Salahuddin SZ; Gallo RC; Albini A Cancer Res; 1991 May; 51(10):2670-6. PubMed ID: 2021945 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation. Guo WX; Gill PS; Antakly T Cancer Res; 1995 Feb; 55(4):823-9. PubMed ID: 7850796 [TBL] [Abstract][Full Text] [Related]
19. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors. Barillari G; Franzese O; Comandini A; Bonmassar E; Ensoli B Oncol Rep; 2010 Jul; 24(1):219-23. PubMed ID: 20514465 [TBL] [Abstract][Full Text] [Related]
20. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]